ArticleCell death & disease2026
MND1 regulates PANoptosis and stemness of lung adenocarcinoma cells by stabilizing RCOR2 mRNA.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
PANoptosis is an inflammatory programmed cell death mechanism that depends on the PANoptosome complex, which integrates hallmark features of apoptosis, necroptosis, and pyroptosis. Meiotic nuclear division protein 1 (MND1), a meiosis-specific protein, primarily participates in homologous chromosome pairing and DNA double-strand break repair. However, the precise role of MND1 in regulating PANoptosis and tumor stemness remains unclear. Here, we provide evidence that MND1 participates in the regulatory mechanisms of PANoptosis and cell stemness in lung adenocarcinoma (LUAD). Mechanistically, MND1 recruits PABPC1 to interact with the 3'-UTR of RCOR2 mRNA, significantly enhancing its stability. As a crucial component of the pluripotency regulatory network, the stable expression of RCOR2 is essential for maintaining tumor cell stemness. Our findings suggest MND1 acts as an oncogene in LUAD by stabilizing RCOR2 mRNA, maintaining the stemness of LUAD and inhibiting PANoptosis. Notably, this study represents the first investigation to elucidate the regulatory role of MND1 in modulating both stemness properties and PANoptosis in LUAD, providing valuable insights into the molecular mechanisms underlying LUAD pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.